Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 153 No. 1 (2023)

Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children: Results from the school-based cohort study Ciao Corona in November–December 2021 in the canton of Zurich

  • Sarah R. Haile
  • Alessia Raineri
  • Sonja Rueegg
  • Thomas Radtke
  • Agne Ulyte
  • Milo A. Puhan
  • Susi Kriemler
DOI
https://doi.org/10.57187/smw.2023.40035
Cite this as:
Swiss Med Wkly. 2023;153:40035
Published
30.01.2023

Summary

BACKGROUND: Much remains unknown regarding the evolution of SARS-CoV-2 seroprevalence and variability in seropositive children in districts, schools and classes as only a few school-based cohort studies exist. Vaccination of children, initiated at different times for different age groups, adds additional complexity to the understanding of how seroprevalence developed in the school aged population.

AIM: We investigated the evolution of SARS-CoV-2 seroprevalence in children and its variability in districts, schools and classes in Switzerland from June/July 2020 to November/December 2021.

METHODS: In this school-based cohort study, SARS-CoV-2 antibodies were measured in primary and secondary school children from randomly selected schools in the canton of Zurich in October/November 2020, March/April 2021 and November/December 2021. Seroprevalence was estimated using Bayesian logistic regression to adjust for test sensitivity and specificity. Variability of seroprevalence between school classes was expressed as maximum minus minimum seroprevalence in a class and summarised as median (interquartile range).

RESULTS: 1875 children from 287 classes in 43 schools were tested, with median age 12 years (range 6–17), 51% 12+ vaccinated. Seroprevalence increased from 5.6% (95% credible interval [CrI] 3.5–7.6%) to 31.1% (95% CrI 27.0–36.1%) in unvaccinated children, and 46.4% (95% CrI 42.6–50.9%) in all children (including vaccinated). Earlier in the pandemic, seropositivity rates in primary schools were similar to or slightly higher (<5%) than those in secondary schools, but by late 2021, primary schools had 12.3% (44.3%) lower seroprevalence for unvaccinated (all) subjects. Variability in seroprevalence among districts and schools increased more than two-fold over time, and in classes from 11% (95% CrI 7–17%) to 40% (95% CrI 22–49%).

CONCLUSION: Seroprevalence in children increased greatly, especially in 2021 following introduction of vaccines. Variability in seroprevalence was high and increased substantially over time, suggesting complex transmission chains.

Trial Registration: ClinicalTrials.gov NCT04448717

References

  1. ECDC. Interim public health considerations for COVID-19 vaccination of children aged 5-11 years, 1 December 2021. [cited 2022 August 1]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/TGU-20211119-1925_final-for-publication.pdf
  2. Viner RM, Mytton OT, Bonell C, Melendez-Torres GJ, Ward J, Hudson L, et al. Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2021 Feb;175(2):143–56. [cited 2021 Feb 1] https://doi.org/10.1001/jamapediatrics.2020.4573 DOI: https://doi.org/10.1001/jamapediatrics.2020.4573
  3. Dawood FS, Porucznik CA, Veguilla V, Stanford JB, Duque J, Rolfes MA, et al. Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York. JAMA Pediatr. 2022 Jan;176(1):59–67. [cited 2022 Jan 1] https://doi.org/10.1001/jamapediatrics.2021.4217 DOI: https://doi.org/10.1001/jamapediatrics.2021.4217
  4. DGPI. Infektions- und Übertragungsrisiken von SARS-CoV-2 und die Marbidität und Mortalität bei Kindern und Jugendlichen. Einfluss von saisonalem Verlauf, Virusvarianten und Impfeffekten. Stellungnahme der Deutschen Gesellschaft für Krankenhaushygiene (DGKH) und der Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI). Berlin 2021 [cited 2021 September 30]. Available from: https://dgpi.de/wp-content/uploads/2021/09/2021-09-13-Stellungnahme-DGPI-DGKH_kurz.pdf
  5. Ben-Shimol S, Livni G, Megged O, Greenberg D, Danino D, Youngster I, et al. COVID-19 in a Subset of Hospitalized Children in Israel. J Pediatric Infect Dis Soc. 2021 Aug;10(7):757–65. [cited 2021 Aug 17] https://doi.org/10.1093/jpids/piab035 DOI: https://doi.org/10.1093/jpids/piab035
  6. Lorthe E, Bellon M, Berthelot J, Michielin G, L’Huillier AG, Posfay-Barbe KM, et al.; SEROCoV-Schools Study Group. A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland. Lancet Infect Dis. 2022 Jun;22(6):767–8. [cited 2022 Jun] https://doi.org/10.1016/S1473-3099(22)00267-5 DOI: https://doi.org/10.1016/S1473-3099(22)00267-5
  7. Vlachos J, Hertegård E, B Svaleryd H. The effects of school closures on SARS-CoV-2 among parents and teachers. Proc Natl Acad Sci USA. 2021 Mar;118(9):e2020834118. [cited 2021 Mar 2] https://doi.org/10.1073/pnas.2020834118 DOI: https://doi.org/10.1073/pnas.2020834118
  8. Lessler J, Grabowski MK, Grantz KH, Badillo-Goicoechea E, Metcalf CJ, Lupton-Smith C, et al. Household COVID-19 risk and in-person schooling. Science. 2021 Jun;372(6546):1092–7. [cited 2021 Jun 4] A https://doi.org/10.1126/science.abh2939 DOI: https://doi.org/10.1126/science.abh2939
  9. Calvani M, Cantiello G, Cavani M, Lacorte E, Mariani B, Panetta V, et al. Reasons for SARS-CoV-2 infection in children and their role in the transmission of infection according to age: a case-control study. Ital J Pediatr. 2021 Sep;47(1):193. [cited 2021 Sep 27] https://doi.org/10.1186/s13052-021-01141-1 DOI: https://doi.org/10.1186/s13052-021-01141-1
  10. RKI. Wöchentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19). Berlin 2021 [cited 2021 October 28]. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2021-10-28.pdf?__blob=publicationFile
  11. ECDC. COVID-19 in children and the role of school settings in tranmission - second update. 2021 [cited 2021 October 28]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-in-children-and-the-role-of-school-settings-in-transmission-second-update.pdf
  12. Chadeau-Hyam M, Eales O, Bodinier B, et al. REACT-1 round 15 final report: Increased breakthrough SARS-CoV-2 infections among adults who had received two doses of vaccine, but booster doses and first doses in children are providing important protection.; London 2021 [cited 2021 October 28]. Available from: https://spiral.imperial.ac.uk/handle/10044/1/92501 DOI: https://doi.org/10.1101/2021.12.14.21267806
  13. Ladhani SN, Ireland G, Baawuah F, Beckmann J, Okike IO, Ahmad S, et al. Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England. EClinicalMedicine. 2022 Feb;45:101319. [cited 2022 Mar] https://doi.org/10.1016/j.eclinm.2022.101319 DOI: https://doi.org/10.1016/j.eclinm.2022.101319
  14. Ladhani SN, Ireland G, Baawuah F, et al. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England. J Infect 2021 [cited 2021 August 30]. DOI: https://doi.org/10.1101/2021.07.14.21260496
  15. Ismail SA, Saliba V, Lopez Bernal J, et al. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England. Lancet Infect Dis 2020 [cited 2020 Dec 8]. DOI: https://doi.org/10.1101/2020.08.21.20178574
  16. Ulyte A, Radtke T, Abela IA, Haile SR, Ammann P, Berger C, et al. Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona. Swiss Med Wkly. 2021 Nov;151(4546):w30092. [cited 2021 Oct 25] https://doi.org/10.4414/SMW.2021.w30092 DOI: https://doi.org/10.4414/SMW.2021.w30092
  17. Ulyte A, Radtke T, Abela IA, Haile SR, Berger C, Huber M, et al. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools. BMJ. 2021 Mar;372(616):n616. [cited 2021 Mar 17] https://doi.org/10.1136/bmj.n616 DOI: https://doi.org/10.1136/bmj.n616
  18. Vardavas C, Nikitara K, Mathioudakis AG, Hilton Boon M, Phalkey R, Leonardi-Bee J, et al. Transmission of SARS-CoV-2 in educational settings in 2020: a review. BMJ Open. 2022 Apr;12(4):e058308. [cited 2022 Apr 5] https://doi.org/10.1136/bmjopen-2021-058308 DOI: https://doi.org/10.1136/bmjopen-2021-058308
  19. Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau AJ, et al.; Specchio-COVID19 study group. Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021. Euro Surveill. 2021 Oct;26(43):2100830. [cited 2021 Oct] https://doi.org/10.2807/1560-7917.ES.2021.26.43.2100830 DOI: https://doi.org/10.2807/1560-7917.ES.2021.26.43.2100830
  20. FDA. Epidemiology of COVID19 in Children Aged 5 – 11 years. Event Materials for Vaccines and Related Biological Products Advisory Committee Meeting October 26. 2021 [cited 2021 2022 August 1]. Available from: https://www.fda.gov/media/153508/download
  21. Merckx J, Roelants M, Callies M, et al. Prevalence and incidence of antibodies against SARS-CoV-2 in children and school staff measured between December 2020 and June 2021: Findings of the third testing period – brief summary. Brussels 2021 [cited 2021 August 1]. Available from: https://www.sciensano.be/sites/default/files/report_seroprev_sars-cov-2_schools_t2_jun2021_1.pdf
  22. Scotland. Population-based seroprevalence surveillance 13 October 2021. Scotland 2021 [cited 2021 October 30]. Available from: https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-13-october-2021/.
  23. Ulyte A, Radtke T, Abela IA, Haile SR, Braun J, Jung R, et al. Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study. Int J Public Health. 2020 Dec;65(9):1549–57. [cited 2020 Dec] https://doi.org/10.1007/s00038-020-01495-z DOI: https://doi.org/10.1007/s00038-020-01495-z
  24. Ulyte A, Radtke T, Abela IA, Haile SR, Blankenberger J, Jung R, et al. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland. BMJ Open. 2021 Jul;11(7):e047483. [cited 2021 Jul 26] https://doi.org/10.1136/bmjopen-2020-047483 DOI: https://doi.org/10.1136/bmjopen-2020-047483
  25. West EA, Anker D, Amati R, Richard A, Wisniak A, Butty A, et al.; Corona Immunitas Research Group. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland. Int J Public Health. 2020 Dec;65(9):1529–48. [cited 2020 Dec] https://doi.org/10.1007/s00038-020-01494-0 DOI: https://doi.org/10.1007/s00038-020-01494-0
  26. Fenwick C, Croxatto A, Coste AT, Pojer F, André C, Pellaton C, et al. Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies. J Virol. 2021 Jan;95(3):e01828-20. [cited 2021 Jan 13] https://doi.org/10.1128/JVI.01828-20 DOI: https://doi.org/10.1128/JVI.01828-20
  27. Zurich Co. Numbers and facts on COVID-19 [Kanton Zürich. Zahlen & Fakten zu COVID-19]. 2021: https://www.zh.ch/de/gesundheit/coronavirus/zahlen-fakten-covid-19.zhweb-noredirect.zhweb-cache.html?keywords=covid19#/. [cited 2021.
  28. R Core Team. R: A language and environment for statistical computing. In: R Foundation for Statistical Computing, ed. Vienna, Austria 2020. [cited 2020 Date]. Available from: https://www.r-project.org/
  29. Stan Development Team. R Stan: the R interface to Stan. 2020 [cited 2020. Available from: https://www.r-project.org/
  30. Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin WH, Wontakal S, et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021 Jan;22(1):25–31. [cited 2021 Jan] https://doi.org/10.1038/s41590-020-00826-9 DOI: https://doi.org/10.1038/s41590-020-00826-9
  31. Tagarro A, Sanz-Santaeufemia FJ, Grasa C, Cobos E, Yebra J, Alonso-Cadenas JA, et al.; EPICO-AEP Working Group. Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection. J Pediatr. 2022 Feb;241:126–132.e3. [cited 2022 Feb] https://doi.org/10.1016/j.jpeds.2021.09.029 DOI: https://doi.org/10.1016/j.jpeds.2021.09.029
  32. Lumley SF, Wei J, O’Donnell D, Stoesser NE, Matthews PC, Howarth A, et al.; Oxford University Hospitals Staff Testing Group. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers. Clin Infect Dis. 2021 Aug;73(3):e699–709. [cited 2021 Aug 2] https://doi.org/10.1093/cid/ciab004 DOI: https://doi.org/10.1101/2020.11.02.20224824
  33. Davies NG, Klepac P, Liu Y, Prem K, Jit M, Eggo RM; CMMID COVID-19 working group. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020 Aug;26(8):1205–11. [cited 2020 Aug] https://doi.org/10.1038/s41591-020-0962-9 DOI: https://doi.org/10.1101/2020.03.24.20043018
  34. Irfan O, Li J, Tang K, et al. Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis. J Glob Health 2021;11:05013. [cited 2021. DOI: https://doi.org/10.7189/jogh.11.05013
  35. Gentles LE, Kehoe L, Crawford KH, et al. Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time. medRxiv 2022 [cited 2022 Jan 25]. https://doi.org/10.1101/2022.01.14.22269235 DOI: https://doi.org/10.1101/2022.01.14.22269235
  36. Zinszer K, McKinnon B, Bourque N, Pierce L, Saucier A, Otis A, et al. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada. JAMA Netw Open. 2021 Nov;4(11):e2135975. [cited 2021 Nov 1] https://doi.org/10.1001/jamanetworkopen.2021.35975 DOI: https://doi.org/10.1001/jamanetworkopen.2021.35975
  37. Ladhani SN, Baawuah F, Beckmann J, Okike IO, Ahmad S, Garstang J, et al. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study. Lancet Child Adolesc Health. 2021 Jun;5(6):417–27. [cited 2021 Jun] https://doi.org/10.1016/S2352-4642(21)00061-4 DOI: https://doi.org/10.1016/S2352-4642(21)00061-4
  38. Bloise S, Marcellino A, Testa A, Dilillo A, Mallardo S, Isoldi S, et al. Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults. Eur J Pediatr. 2021 Nov;180(11):3335–42. [cited 2021 Nov] https://doi.org/10.1007/s00431-021-04124-w DOI: https://doi.org/10.1007/s00431-021-04124-w

Most read articles by the same author(s)

1 2 > >>